International Update

Malaysia sees investment in a major production facility; OpenAI launches its first data center location in Europe; Nissui Corporation expands its office and operations in Kitakyushi, Japan; French aerospace company Safran selects a location for its 323,000-sq.-ft aircraft carbon brake manufacturing facility; and Hong-Kong based Quasar Medical expands into Thailand and Singapore.

How is Vietnam joining the ranks of Asia’s most dynamic economies?

International logistics company DP World is establishing a new free trade zone at the Port of Caucedo in the Dominican Republic. The FTZ will encompass over 555 acres at the port, whose presence will increase current twenty-foot equivalent unit (TEU) capacity from 2.5 million to 3.1 million.

Green steel production is thriving in Scandinavia.

Building out the AI infrastructure and workforce in Africa proves to be an ambitious and necessary undertaking.

China continues to attract a steady stream of foreign direct investments as innovation-led sectors gear up.

What is impacting economic activity at the U.S.-Mexico border?

The dozen happiest countries; a data center JV in London; AstraZeneca R&D in Beijing; Hitachi Energy in Finland; Maruti Suzuki in Gujarat, India; Kingspan Group in Ukraine.

Telesat’s new campus in Gatineau, part of the nation’s capital region, will have a national impact.

Exclusive insights from a Pepsico Global Real Estate leader.

A look at how low-tax jurisdictions perform in corporate project attraction.

Pfizer has announced that it invested $743 million to expand its four-year-old Active Pharmaceutical Ingredient (API) plant at Singapore’s Tuas Biomedical Park. At 429,000 sq. ft., the upgraded facility will begin production of small molecule APIs used in the pharmaceutical manufacturer’s oncology, pain and antibiotic medicines.

Tens of billions of dollars in projects are headed to Saudi Arabia. Many are in the surging AI space, and one big one is in HVAC.

Market access, resources and a diversifying economy propel an FDI juggernaut.

Tractus Asia Co-Founder John Evans offers his perspective on a new level of uncertainty and risk in global site selection.

Pfizer has announced that it invested $743 million to expand its four-year-old Active Pharmaceutical Ingredient (API) plant at Singapore’s Tuas Biomedical Park. At 429,000 sq. ft., the upgraded facility will begin production of small molecule APIs used in the pharmaceutical manufacturer’s oncology, pain and antibiotic medicines.